INFAH Delegation Meets DCGI to Strengthen Access to Veterinary Drugs and Vaccines

New Delhi, June 2026: A delegation from the Indian Federation of Animal Health Companies (INFAH) met with Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India (DCGI), to discuss a series of policy proposals and regulatory initiatives aimed at improving access to veterinary medicines and vaccines across the country.

The delegation was led by Dr. Arun Atrey, Chairperson of INFAH’s Therapeutics Subcommittee, and Dr. Vijay Makhija, Chairperson of the Biological and Biosecurity Subcommittee. The meeting focused on strengthening India’s veterinary healthcare ecosystem by facilitating timely availability of quality veterinary pharmaceuticals and biologicals for livestock and companion animals.

During the interaction, the INFAH representatives presented a comprehensive set of recommendations covering regulatory reforms, faster access to innovative veterinary therapeutics and vaccines, and measures to support the continued growth of India’s animal health sector. The proposals were aimed at enhancing animal health outcomes while supporting disease prevention, food security, livestock productivity and public health.

The delegation emphasized the importance of a progressive and science-based regulatory framework that enables the introduction of new veterinary medicines and biological products while maintaining high standards of safety, quality and efficacy.

INFAH also expressed its appreciation to the Central Drugs Standard Control Organisation (CDSCO) and its officials for their continued engagement with the animal health industry and for their support in addressing regulatory matters affecting member companies.

According to participants, Dr. Raghuvanshi acknowledged the industry’s recommendations and reiterated the regulator’s commitment to maintaining an open dialogue with stakeholders. He assured the delegation that similar consultative interactions would continue in the future to facilitate collaborative policy development and strengthen India’s veterinary healthcare regulatory ecosystem.

The meeting reflects the increasing collaboration between regulators and the animal health industry as India seeks to improve access to advanced veterinary medicines, enhance livestock health management, strengthen biosecurity preparedness and support the country’s expanding dairy, poultry, swine, aquaculture and companion animal sectors.

Industry stakeholders believe that continued engagement between government authorities and the veterinary pharmaceutical industry will play an important role in accelerating innovation, improving animal disease control programmes and ensuring the availability of high-quality veterinary healthcare solutions across the country.